Real world safety outcomes of an outpatient lymphoma bispecific antibody program: A single center experience from Johns Hopkins.
Year: 2025
Type: conference-abstract
Study design: Observational Study
Source: Journal of Clinical Oncology
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410822196
